This identification of CDK5 confirmed that G9a is a broad regulator of AD proteopathologic landscape, hence, MS1262 rescued a range of AD-dysregulated pathways that define multiple AD pathological hallmarks such as Aβ plaque and NFT pathology. Here, EHMT2 is linked to Alzheimer disease.